ライフサイエンスコーパス: hepatitis B virus infection

1 with HIV infection are at increased risk for hepatitis B virus infection.

2 n the nationwide vaccination program against hepatitis B virus infection.

3 survival rates among women who have chronic hepatitis B virus infection.

4 e attributed to alcoholism or active chronic hepatitis B virus infection.

5 patocellular carcinoma (HCC) associated with hepatitis B virus infection.

6 umors, most of which were related to chronic hepatitis B virus infection.

7 B vaccine is an effective measure to prevent hepatitis B virus infection.

8 lasmic reticulum of human liver cells during hepatitis B virus infection.

9 ntigens in a transgenic mouse model of acute hepatitis B virus infection.

10 ver disease pathogenesis associated with the hepatitis B virus infection.

11 e process of tumor progression after chronic hepatitis B virus infection.

12 ean age +/-SD, 42 +/- 13 years) with chronic hepatitis B virus infection.

13 ular carcinoma (HCC) associated with chronic hepatitis B virus infection.

14 serological evidence of posttransplantation hepatitis B virus infection.

15 t of hepatocellular carcinoma during chronic hepatitis B virus infection.

16 ons, in contrast to the role of TNF-alpha in hepatitis B virus infections.

17 drug-induced liver injury DILI (22%), acute hepatitis B virus infection (12%), autoimmune hepatitis

18 C virus infection (41%), alcohol (39%), and hepatitis B virus infection (22%) the commonest etiologi

19 and obesity; 12.5% (95% CI: 10.6-14.3%) for hepatitis B virus infection; 29.1% (95% CI: 23.6-34.5%)

20 For lamivudine resistant hepatitis B virus infection, adefovir should be added to

21 ion found in human hepatomas associated with hepatitis B virus infection and aflatoxin exposure.

22 incidence of HCC is strongly associated with hepatitis B virus infection and dietary exposure to hepa

23 es can be interrupted by vaccination against hepatitis B virus infection and improvements in medical

24 n in creating immunological tolerance during hepatitis B virus infection and propose mechanisms for h

25 bserved in patients who successfully cleared hepatitis B virus infection and to influenza-specific me

26 fibrosis, as were daily alcohol use, chronic hepatitis B virus infection, body mass index greater tha

27 ciation between hepatocellular carcinoma and hepatitis B virus infection, but not with hepatitis C vi

28 It is well known that hepatitis B virus infections can be transient or chronic

29 an guidelines recommend treatment of chronic hepatitis B virus infection (CHB) with the nucleos(t)ide

30 IL-10 is elevated in patients with chronic hepatitis B virus infection (CHB), but its cellular sour

31 antigen (HBsAg) testing to identify chronic hepatitis B virus infection for foreign-born persons fro

32 nt studies using a transgenic mouse model of hepatitis B virus infection have shown that adoptively t

33 A cross-sectional analysis of prevalence of hepatitis B virus infection (HBV) among rural couples wa

34 s processes, including hepatitis C virus and hepatitis B virus infections, hepatoxicity associated wi

35 age, male gender, African-American ancestry, hepatitis B virus infection, HIV-1 infection, and IL28B

36 ly useful approach to the control of chronic hepatitis B virus infection in humans.

37 omosexual men who participated in studies of hepatitis B virus infection in the late 1970s in New Yor

38 ients in their 40s with perinatally acquired hepatitis B virus infection increases the risk for cirrh

39 Chronic hepatitis B virus infection is a leading cause of cirrho

40 Hepatitis B virus infection is a major public health pro

41 Effective prevention and treatment of hepatitis B virus infection is an important public healt

42 Hepatitis B virus infection is associated with hepatocel

43 ca, the world's most populous nations, where hepatitis B virus infection is endemic.

44 The nature of host-virus interactions in hepatitis B virus infection is incompletely understood.

45 The correlate of protection from hepatitis B virus infection is serum antibody titers ind

46 Hepatitis-B virus infection is globally ubiquitous, but

47 f c-jun, should they occur in the context of hepatitis B virus infection, might play a role in viral

48 and effective as initial therapy for chronic hepatitis B virus infection or for the management of lam

49 apeutic strategy in the treatment of chronic hepatitis B virus infection or other chronic viral disea

50 Hepatitis B virus infection originating from hepatitis B

51 Chronic hepatitis B virus infection predicted longer survival.

52 ic Health Management of Persons with Chronic Hepatitis B Virus Infection, recommending screening for

53 ear-old woman with medical history of latent hepatitis B virus infection, repeated choledocholisthias

54 copies per mL); HLA-B*5701-negative; had no hepatitis B virus infection; screening genotypes showing

55 The initial evaluation of a patient with hepatitis B virus infection should attempt to assess the

56 A total of 3087 individuals with chronic hepatitis B virus infection were enrolled between 1991 a

57 n the early 1980s, results of LT for chronic hepatitis B virus infection were hampered by recurrent i

58 No new acute or chronic hepatitis B virus infections were identified.

59 5-year-old woman with a life-long history of hepatitis B virus infection who is awaiting transplant,

60 n and 15% of women with perinatally acquired hepatitis B virus infection will die of liver cirrhosis

61 nalysis of HCC samples from 76 patients with hepatitis B virus infection with data on patient surviva

62 f LT, center, and hepatitis C virus (HCV) or hepatitis B virus infection) with non-HIV-infected contr